UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity

Gastroenterology (New York, N.Y. 1943), 2013-11, Vol.145 (5), p.987-995

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study

The Lancet infectious diseases, 2017-07, Vol.17 (7), p.735-744

2017

Link zum Volltext

Verfügbarkeit prüfen

Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy

Current therapeutic research, 2022-01, Vol.96, p.100667-100667, Article 100667

2022

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS]

Journal of Crohn's and colitis, 2015-08, Vol.9 (8), p.607-616

2015

Link zum Volltext

Verfügbarkeit prüfen

Mo1682 Differential Success Predictors for Ulcerative Colitis Patients Treated With Mesalamine Using Proteomics

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-658-S-658

2012

Link zum Volltext

Verfügbarkeit prüfen

Tu1724 A Role for yIFN in Clostridium difficile Infection

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-831-S-831

2013

Link zum Volltext

Verfügbarkeit prüfen

Su1281 Recognition That Angioectatic Lesions Use the TGF Beta Pathway Demonstrates a Novel Data-Based Model for Clinical Drug Development

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-446-S-446

2013

Link zum Volltext

Verfügbarkeit prüfen

Mo1113 Clostridium difficile Surface Layer Protein (SLP) Elicits Differential Cytokine Responses in Initial and Recurrent Patients

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-598-S-598

2012

Link zum Volltext

Verfügbarkeit prüfen

Mo1114 The Balance of T Regulatory: TH17 Cells May Play a Role in Clostridium difficile Clearance

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-598-S-599

2012

Link zum Volltext

Verfügbarkeit prüfen

A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease

Gastroenterology (New York, N.Y. 1943), 1998-06, Vol.114 (6), p.1133-1142

1998

Link zum Volltext

Verfügbarkeit prüfen

1028 Novel Proteomic Assessment for the Development of IBD in Active Duty US Military Personnel

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-192-S-192

2013

Link zum Volltext

Verfügbarkeit prüfen

591 HUMAN BIOPSY-DERIVED COLONOIDS ARE USEFUL TO STUDY LUMINAL C DIFFICILE INFECTION AND THE RELATIVE BENEFIT OF ACTOXUMAB OR BEZLOTOXUMAB

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-126-S-127

2020

Link zum Volltext

Verfügbarkeit prüfen

Tu1057 Favorable Cost-Benefit Analysis Justifies the Implementation of Higher Sensitivity Molecular Testing for C. difficile

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-733-S-733

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Goblet Cell Populations in HLA B27 Rats Before and After Treatment With the Soluble Fiber Carboxymethylcellulose

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-850-S-850

2011

Link zum Volltext

Verfügbarkeit prüfen

558 Influence of Symptom Knowledge and History on Disease Scoring With the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-103-S-103

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2020-02, Vol.158 (3), p.550-561

2020

Link zum Volltext

Verfügbarkeit prüfen

Sa1116 BISMUTH SUBSALICYLATE ALTERS THE EFFECTS OF CHOLERA TOXIN IN A HUMAN COLONOID MODEL

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-280-S-281

2020

Link zum Volltext

Verfügbarkeit prüfen

Fusobacterium nucleatum Adheres to Clostridioides difficile via the RadD Adhesin to Enhance Biofilm Formation in Intestinal Mucus

Gastroenterology (New York, N.Y. 1943), 2021-03, Vol.160 (4), p.1301-1314.e8

2021

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Occult Gastrointestinal Bleeding in Celiac Disease

Clinical gastroenterology and hepatology, 2006-04, Vol.4 (4), p.451-454

2006

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2021-09, Vol.161 (3), p.837-852.e9

2021

Link zum Volltext

Verfügbarkeit prüfen

Sa1284 FOXP3+ Cd3− Cells in Clostridium difficile Infection (CDI)

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-251-S-252

2014

Link zum Volltext

Verfügbarkeit prüfen

Mo1670 Role for Differences in TLR Expression in the Clearance of Clostridium difficile Infections

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S748-S748

2016

Link zum Volltext

Verfügbarkeit prüfen

702 Efficacy and Safety of Delayed-Release Oral mesalamine At 4.8g/D (800mg Tablet) in the Treatment of Moderately Active Ulcerative Colitis: Results of the Ascend III Study

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-99-A-99

2008

Link zum Volltext

Verfügbarkeit prüfen

P139 OLORINAB, A PERIPHERALLY RESTRICTED, HIGHLY SELECTIVE AGONIST OF THE CANNABINOID RECEPTOR TYPE 2 FOR THE MANAGEMENT OF VISCERAL PAIN IN INFLAMMATORY BOWEL DISEASE (IBD) – PRECLINICAL AND EARLY CLINICAL DEVELOPMENT

Gastroenterology (New York, N.Y. 1943), 2019-02, Vol.156 (3), p.S92-S93

2019

Link zum Volltext

Verfügbarkeit prüfen

Fusobacteriumnucleatum Adheres to Clostridioides difficile via the RadD Adhesin to Enhance Biofilm Formation in Intestinal Mucus

Gastroenterology (New York, N.Y. 1943), 2021-03, Vol.160 (4), p.1301-1314.e8

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 48

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Gastroenterology
(40)
Clinical Gastroenterology And Hepatology
(2)
Clin Gastroenterol Hepatol
(1)
Clinical Biochemistry
(1)
Current Therapeutic Research
(1)
Human Immunology
(1)
Journal Of Crohn's And Colitis
(1)
The Lancet
(1)
The Lancet Infectious Diseases
(1)

4 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity

Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study

Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy

The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS]

Mo1682 Differential Success Predictors for Ulcerative Colitis Patients Treated With Mesalamine Using Proteomics

Tu1724 A Role for yIFN in Clostridium difficile Infection

Su1281 Recognition That Angioectatic Lesions Use the TGF Beta Pathway Demonstrates a Novel Data-Based Model for Clinical Drug Development

Mo1113 Clostridium difficile Surface Layer Protein (SLP) Elicits Differential Cytokine Responses in Initial and Recurrent Patients

Mo1114 The Balance of T Regulatory: TH17 Cells May Play a Role in Clostridium difficile Clearance

A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease

1028 Novel Proteomic Assessment for the Development of IBD in Active Duty US Military Personnel

591 HUMAN BIOPSY-DERIVED COLONOIDS ARE USEFUL TO STUDY LUMINAL C DIFFICILE INFECTION AND THE RELATIVE BENEFIT OF ACTOXUMAB OR BEZLOTOXUMAB

Tu1057 Favorable Cost-Benefit Analysis Justifies the Implementation of Higher Sensitivity Molecular Testing for C. difficile

Evaluation of Goblet Cell Populations in HLA B27 Rats Before and After Treatment With the Soluble Fiber Carboxymethylcellulose

558 Influence of Symptom Knowledge and History on Disease Scoring With the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis

Sa1116 BISMUTH SUBSALICYLATE ALTERS THE EFFECTS OF CHOLERA TOXIN IN A HUMAN COLONOID MODEL

Fusobacterium nucleatum Adheres to Clostridioides difficile via the RadD Adhesin to Enhance Biofilm Formation in Intestinal Mucus

Prevalence of Occult Gastrointestinal Bleeding in Celiac Disease

A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn’s Disease

Sa1284 FOXP3+ Cd3− Cells in Clostridium difficile Infection (CDI)

Mo1670 Role for Differences in TLR Expression in the Clearance of Clostridium difficile Infections

702 Efficacy and Safety of Delayed-Release Oral mesalamine At 4.8g/D (800mg Tablet) in the Treatment of Moderately Active Ulcerative Colitis: Results of the Ascend III Study

P139 OLORINAB, A PERIPHERALLY RESTRICTED, HIGHLY SELECTIVE AGONIST OF THE CANNABINOID RECEPTOR TYPE 2 FOR THE MANAGEMENT OF VISCERAL PAIN IN INFLAMMATORY BOWEL DISEASE (IBD) – PRECLINICAL AND EARLY CLINICAL DEVELOPMENT

Fusobacteriumnucleatum Adheres to Clostridioides difficile via the RadD Adhesin to Enhance Biofilm Formation in Intestinal Mucus

Aktive Filter

Suchergebnisse filtern